121
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Enhanced Activation of mTOR Signaling Pathway Was Found in the Hypertrophic and Nodular Lesions of Port Wine Stains

, , , & ORCID Icon
Pages 643-651 | Published online: 13 Apr 2022

References

  • Barsky SH, Rosen S, Geer DE, et al. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol. 1980;74(3):154–157. doi:10.1111/1523-1747.ep12535052
  • Martinez-Lopez A, Salvador-Rodriguez L, Montero-Vilchez T, et al. Malformations syndromes: an update. Curr Opin Pediatr. 2019;31(6):747–753. doi:10.1097/MOP.0000000000000812
  • Galligan ER, Baselga E, Frieden IJ, et al. Characterization of vascular stains associated with high flow. J Am Acad Dermatol. 2021;84(3):654–660. doi:10.1016/j.jaad.2020.06.985
  • Lee MS, Liang MG, Mulliken JB. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol. 2013;69(4):589–594. doi:10.1016/j.jaad.2013.05.030
  • Frigerio A, Wright K, Wooderchak-Donahue W, et al. Genetic variants associated with port-wine stains. PLoS One. 2015;10(7):e0133158. doi:10.1371/journal.pone.0133158
  • Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166(4):1048–54.el-5.
  • Lee KT, Park JE, Eom Y, et al. Phenotypic association of presence of a somatic GNAQ mutation with port-wine stain distribution in capillary malformation. Head Neck. 2019;41(12):4143–4150. doi:10.1002/hed.25962
  • du Rusquec P, Blonz C, Js F, et al. Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer. Ther Adv Med Oncol. 2020;12:1–12. doi:10.1177/1758835920940939
  • Musalem HM, Alshaikh AA, Tuleimat LM, et al. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone. Ann Saudi Med. 2018;38(5):376–380. doi:10.5144/0256-4947.2018.376
  • Marqués L, Núñez-Córdoba JM, Aguado L, et al. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial. J Am Acad Dermatol. 2015;72(1):151–8.e1. doi:10.1016/j.jaad.2014.10.011
  • Finley JL, Noe JM, Arndt KA, et al. Port-wine stains. Morphologic variations and developmental lesions. Arch Dermatol. 1984;120(11):1453–1455. doi:10.1001/archderm.1984.01650470059013
  • van Drooge AM, Beek JF, van der Veen JP, et al. Hypertrophy in port-wine stains: prevalence and patient characteristics in a large patient cohort. J Am Acad Dermatol. 2012;67(6):1214–1219. doi:10.1016/j.jaad.2012.05.027
  • Tan W, Nadora DM, Gao L, et al. The somatic GNAQ mutation (R183Q) is primarily located within the blood vessels of port wine stains. J Am Acad Dermatol. 2016;74(2):380–383. doi:10.1016/j.jaad.2015.09.063
  • Pérez-Alea M, Vivancos A, Caratú G, et al. Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway. Oncotarget. 2016;7(19):28086–28095. doi:10.18632/oncotarget.8578
  • Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–293. doi:10.1016/j.cell.2012.03.017
  • Mercurio L, Albanesi C, Madonna S. Recent updates on the Involvement of PI3K/AKT/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders. Front Med. 2021;8:665647. doi:10.3389/fmed.2021.665647
  • Mathes EF, Frieden IJ. Early use of laser for port-wine stains: timing, efficacy, and shared decision making. JAMA Dermatol. 2019;155(4):421–423. doi:10.1001/jamadermatol.2018.5189
  • Lee JW, Chung HY. Capillary malformations (port-wine stains) of the head and neck: natural history, investigations, laser, and surgical management. Otolaryngol Clin North Am. 2018;51(1):197–211. doi:10.1016/j.otc.2017.09.004
  • Bae YC, Alabdulrazzaq H, Brauer JA, et al. Treatment of recalcitrant port-wine stains (PWS) using a combined pulsed dye laser (PDL) and radiofrequency (RF) energy device. J Am Acad Dermatol. 2017;76(2):321–326. doi:10.1016/j.jaad.2016.03.004
  • Greveling K, Prens EP, van Doorn MB. Treatment of port wine stains using pulsed dye laser, erbium YAG laser, and topical rapamycin (sirolimus)-A randomized controlled trial. Lasers Surg Med. 2017;49(1):104–109. doi:10.1002/lsm.22548
  • Manning BD. Game of TOR - The target of rapamycin rules four kingdoms. N Engl J Med. 2017;377(13):1297–1299. doi:10.1056/NEJMcibr1709384
  • Zhang P, Han G, Gao P, et al. Protective effect of silymarin against rapamycin-induced apoptosis and proliferation inhibition in endothelial progenitor cells. Nat Prod Commun. 2015;10(2):263–266.
  • Kratzsch T, Piffko A, Broggini T, et al. Role of mTOR and VEGFR inhibition in prevention of metastatic tumor growth in the spine. Front Oncol. 2020;10:174. doi:10.3389/fonc.2020.00174